TABLE 3.
Anti‐S status after second vaccine | |||||||
---|---|---|---|---|---|---|---|
All participants | Myeloma | Smouldering myeloma | |||||
<50 iu/ml | ≥50 iu/ml | <50 iu/ml | ≥50 iu/ml | <50 iu/ml | ≥50 iu/ml | ||
T spot | n = 12 | n = 155 | n = 12 | n = 146 | n = 9 | ||
Negative | n = 65 | 10 (15.4%) | 55 (84.6%) | 10 (16.4%) | 51 (83.6%) | 4 | |
Positive | n = 102 | 2 (2.0%) | 100 (98.0%) | 2 (2.1%) | 95 (97.4%) | 5 |
n = 167.3 patients had indeterminate T‐spot results whose data not shown. Row percentages shown. Fisher's exact p = 0.001 for all participants and myeloma participants.